Germline mutations in TP53 are associated with Li-Fraumeni syndrome, characterized by an increased risk of various cancers, including brain tumors, breast cancer, leukemia, sarcoma, adrenocortical carcinoma, and colon cancer (5). Here, TP53 is linked to Li-Fraumeni syndrome.